Figure 4.

Timing of actual follow-up visits with respect to the scheduled date. Data are provided for visits at which progression to stage 2 was detected (n = 99), as well as all other visits (n = 4774).

Checchi et al. BMC Infectious Diseases 2008 8:16   doi:10.1186/1471-2334-8-16
Download authors' original image